Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04750902 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children
A Phase 2 study of Dental Caries, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,000
- Enrollment target
- 9
- Study locations
NCT04750902 is a Phase 2 study of Dental Caries that has completed, run by Colgate Palmolive. The registered enrollment target is 2,000 participants, above the 655-participant average among 30 other Dental Caries trials with a reported enrollment target (205% higher). The trial reports 9 study locations across 8 states.
The verdict
NCT04750902, a Phase 2 study of Dental Caries, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,000 participants
- Enrollment target
- 9
- Study locations
Study Summary
The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.
Conditions Studied
Interventions
- DRUG 0.24% Sodium Fluoride Dentifrice
- DRUG 1.5% Arginine Dentifrice
- DRUG 4.0% Arginine Dentifrice
- DRUG 8.0% Arginine Dentifrice
Study Locations (9)
Massachusetts
- Tufts University School of Dental Medicine - Boston
- The Forsyth Institute - Boston
California
- Loma Linda University School of Dentistry - Loma Linda
Florida
- University of Florida College of Dentistry - Gainesville
Indiana
- Indiana University School of Dentistry - Indianapolis
New York
- University at Buffalo School of Dental Medicine - Buffalo
Pennsylvania
- University of Pennsylvania School of Dental Medicine - Philadelphia
Texas
- UT Health San Antonio School of Dentistry - San Antonio
Other
- University of Puerto Rico School of Dental Medicine - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2024-02-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04750902
The ClinicalTrials.gov registry entry for NCT04750902 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 655-participant average among 30 other Dental Caries trials with a reported enrollment target (205% higher). The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 4 interventions - of which 0.24% Sodium Fluoride Dentifrice is the first listed.
NCT04750902 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Massachusetts, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04750902 about?
NCT04750902 is a clinical study titled "A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children". The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.
What is the current status of trial NCT04750902?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,000 participants. The study started on 2021-01-21. Estimated completion is 2024-02-29.
What conditions does trial NCT04750902 study?
This clinical trial studies the following conditions: Dental Caries.
What interventions are being tested in trial NCT04750902?
The interventions under investigation include: 0.24% Sodium Fluoride Dentifrice (DRUG), 1.5% Arginine Dentifrice (DRUG), 4.0% Arginine Dentifrice (DRUG), 8.0% Arginine Dentifrice (DRUG).
Who is sponsoring clinical trial NCT04750902?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04750902 being conducted?
This trial has 9 study locations across California, Florida, Indiana, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
COMPLETED · Phase 2
-
Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth
RECRUITING · NA
-
LT Comparative Effectiveness of 2 Caries Treatments
RECRUITING · NA
-
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.